Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 75

1.

Role of integrin β1 as a biomarker of stemness in head and neck squamous cell carcinoma.

Moon JH, Rho YS, Lee SH, Koo BS, Lee HJ, Do SI, Cho JH, Eun YG, Park MW, Shin HA, Lim YC.

Oral Oncol. 2019 Sep;96:34-41. doi: 10.1016/j.oraloncology.2019.07.001. Epub 2019 Jul 4.

PMID:
31422211
2.

Association between Circulating Fibroblast Growth Factor 21 and Aggressiveness in Thyroid Cancer.

Kang YE, Kim JT, Lim MA, Oh C, Liu L, Jung SN, Won HR, Lee K, Chang JW, Yi HS, Kim HJ, Ku BJ, Shong M, Koo BS.

Cancers (Basel). 2019 Aug 12;11(8). pii: E1154. doi: 10.3390/cancers11081154.

3.

Efficacy of three proton-pump inhibitor therapeutic strategies on laryngopharyngeal reflux disease; a prospective randomized double-blind study.

Yoon YH, Park KW, Lee SH, Park HS, Chang JW, Koo BS.

Clin Otolaryngol. 2019 Jul;44(4):612-618. doi: 10.1111/coa.13345. Epub 2019 May 6.

PMID:
31002475
4.

Evolving Strategy for Surgical Management of Oral Cancer: Present and Future.

Joo YH, Koo BS.

Clin Exp Otorhinolaryngol. 2019 May;12(2):101-102. doi: 10.21053/ceo.2019.00164. Epub 2019 Mar 29. No abstract available.

5.

Guidelines for the Surgical Management of Oral Cancer: Korean Society of Thyroid-Head and Neck Surgery.

Joo YH, Cho JK, Koo BS, Kwon M, Kwon SK, Kwon SY, Kim MS, Kim JK, Kim H, Nam I, Roh JL, Park YM, Park IS, Park JJ, Shin SC, Ahn SH, Won S, Ryu CH, Yoon TM, Lee G, Lee DY, Lee MC, Lee JK, Lee JC, Lim JY, Chang JW, Jang JY, Chung MK, Jung YS, Cho JG, Choi YS, Choi JS, Lee GH, Chung PS.

Clin Exp Otorhinolaryngol. 2019 May;12(2):107-144. doi: 10.21053/ceo.2018.01816. Epub 2019 Feb 2.

6.

Optimal extent of lateral neck dissection for well-differentiated thyroid carcinoma with metastatic lateral neck lymph nodes: A systematic review and meta-analysis.

Won HR, Chang JW, Kang YE, Kang JY, Koo BS.

Oral Oncol. 2018 Dec;87:117-125. doi: 10.1016/j.oraloncology.2018.10.035. Epub 2018 Nov 1. Review.

PMID:
30527226
7.

LAMB3 is associated with disease progression and cisplatin cytotoxic sensitivity in head and neck squamous cell carcinoma.

Liu L, Jung SN, Oh C, Lee K, Won HR, Chang JW, Kim JM, Koo BS.

Eur J Surg Oncol. 2019 Mar;45(3):359-365. doi: 10.1016/j.ejso.2018.10.543. Epub 2018 Nov 2.

PMID:
30414703
8.

Clinical significance of extrathyroidal extension according to primary tumor size in papillary thyroid carcinoma.

Liu L, Oh C, Heo JH, Park HS, Lee K, Chang JW, Jung SN, Koo BS.

Eur J Surg Oncol. 2018 Nov;44(11):1754-1759. doi: 10.1016/j.ejso.2018.05.009. Epub 2018 Jun 12.

PMID:
29934055
9.

Clinical Implications of UCP1 mRNA Expression in Human Cervical Adipose Tissue Under Physiological Conditions.

Lee JH, Kim JM, Choi MJ, Kang YE, Joung KH, Yi HS, Kim KS, Ku BJ, Koo BS, Shong M, Kim HJ.

Obesity (Silver Spring). 2018 Jun;26(6):1008-1016. doi: 10.1002/oby.22188. Epub 2018 Apr 26.

10.

LAMB3 mediates metastatic tumor behavior in papillary thyroid cancer by regulating c-MET/Akt signals.

Jung SN, Lim HS, Liu L, Chang JW, Lim YC, Rha KS, Koo BS.

Sci Rep. 2018 Feb 9;8(1):2718. doi: 10.1038/s41598-018-21216-0.

11.

Upregulation of RSPO2-GPR48/LGR4 signaling in papillary thyroid carcinoma contributes to tumor progression.

Kang YE, Kim JM, Kim KS, Chang JY, Jung M, Lee J, Yi S, Kim HW, Kim JT, Lee K, Choi MJ, Kang SK, Lee SE, Yi HS, Koo BS, Shong M.

Oncotarget. 2017 Nov 25;8(70):114980-114994. doi: 10.18632/oncotarget.22692. eCollection 2017 Dec 29.

12.

Detection of voice changes due to aspiration via acoustic voice analysis.

Kang YA, Kim J, Jee SJ, Jo CW, Koo BS.

Auris Nasus Larynx. 2018 Aug;45(4):801-806. doi: 10.1016/j.anl.2017.10.007. Epub 2017 Oct 31.

PMID:
29097046
13.

Inhibitor of DNA binding 2 is a novel therapeutic target for stemness of head and neck squamous cell carcinoma.

Bae WJ, Koo BS, Lee SH, Kim JM, Rho YS, Lim JY, Moon JH, Cho JH, Lim YC.

Br J Cancer. 2017 Dec 5;117(12):1810-1818. doi: 10.1038/bjc.2017.373. Epub 2017 Nov 2.

14.

Relationship Between 18F-fluorodeoxyglucose Accumulation and the BRAF V600E Mutation in Papillary Thyroid Cancer.

Chang JW, Park KW, Heo JH, Jung SN, Liu L, Kim SM, Kwon IS, Koo BS.

World J Surg. 2018 Jan;42(1):114-122. doi: 10.1007/s00268-017-4136-y.

PMID:
28808756
15.

High Expression of Angiopoietin-1 is Associated with Lymph Node Metastasis and Invasiveness of Papillary Thyroid Carcinoma.

Kang YE, Kim KS, Park SJ, Jung SN, Chang JW, Yi S, Jung MG, Kim JM, Koo BS.

World J Surg. 2017 Dec;41(12):3128-3138. doi: 10.1007/s00268-017-4111-7.

PMID:
28717903
16.

Clinical implications of microscopic extrathyroidal extension in patients with papillary thyroid carcinoma.

Park JS, Chang JW, Liu L, Jung SN, Koo BS.

Oral Oncol. 2017 Sep;72:183-187. doi: 10.1016/j.oraloncology.2017.02.008. Epub 2017 Feb 20.

PMID:
28222967
17.

Change of Swallowing in Patients With Head and Neck Cancer After Concurrent Chemoradiotherapy.

Kweon S, Koo BS, Jee S.

Ann Rehabil Med. 2016 Dec;40(6):1100-1107. doi: 10.5535/arm.2016.40.6.1100. Epub 2016 Dec 30.

18.

Transforming growth factor β1 enhances stemness of head and neck squamous cell carcinoma cells through activation of Wnt signaling.

Bae WJ, Lee SH, Rho YS, Koo BS, Lim YC.

Oncol Lett. 2016 Dec;12(6):5315-5320. doi: 10.3892/ol.2016.5336. Epub 2016 Nov 2.

19.

Clinical implications of the extent of BRAFV600E alleles in patients with papillary thyroid carcinoma.

Liu L, Chang JW, Jung SN, Park HS, Oh T, Lim YC, Koo BS.

Oral Oncol. 2016 Nov;62:72-77. doi: 10.1016/j.oraloncology.2016.10.005. Epub 2016 Oct 19.

PMID:
27865374
20.

Lateral lymph node recurrence after total thyroidectomy and central neck dissection in patients with papillary thyroid cancer without clinical evidence of lateral neck metastasis.

Lim YC, Liu L, Chang JW, Koo BS.

Oral Oncol. 2016 Nov;62:109-113. doi: 10.1016/j.oraloncology.2016.10.010. Epub 2016 Oct 22.

PMID:
27865362

Supplemental Content

Loading ...
Support Center